AMP 2022 Annual Meeting

September 1, 2022

The Association for Molecular Pathology (AMP) 2022 Annual Meeting is taking place November 1–5 in Phoenix, AZ. AMP is a leading organization for molecular diagnostics and is anticipating over 2,000 attendees. Haystack Oncology will be exhibiting at booth #1723. We’re looking forward to a dynamic and engaging scientific program, as well as conversations about improving patient outcomes with cutting-edge precision oncology. We hope to see you there!

Subscribe for updates

No spam, notifications only about new products, updates.

News and events

American Association for Cancer Research 2024

April 3, 2024

Haystack MRD™ by Quest Diagnostics® will be attending the 2024 American Association for Cancer Research (AACR) annual meeting taking place April 5–10, 2024 in San Diego, CA. The AACR annual meeting stands as the cornerstone of the cancer research community,

Haystack Oncology, developer of Haystack MRD™, and TriSalus Life Sciences collaborate in connection with the clinical development of TriSalus’ TLR9 agonist in hepatocellular carcinoma, intrahepatic cholangiocarcinoma, and pancreatic adenocarcinoma

April 3, 2024

Haystack Oncology, a Quest Diagnostics (NYSE: DGX) company and developer of best-in-class personalized MRD technology (Haystack MRD™), has entered a research collaboration with TriSalus Life Sciences to evaluate therapeutic response and provide molecular insights in connection with the clinical development

More news and events

Follow us on social media

Make better decisions with better MRD testing

Connect with us

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. © 2024 Quest Diagnostics Incorporated. All rights reserved.